Skip to main content
Northwestern University Feinberg School of Medicine
Center for Dissemination & Implementation Science

MBC2OTP

Pilot Implementation of Measurement-Based Care in Community Opioid Treatment Programs

This early-career development award is evaluating the preliminary effectiveness and implementation of measurement-based care (MBC) as a means to enhance the quality of care in opioid treatment programs (OTPs). In phase one of the research plan, Principal Investigator (PI) Kelli Scott, PhD, will work with eight opioid treatment programs (OTPs) to develop community-engaged research partnerships, complete site visits, and engage OTP staff and patients in qualitative interviews and quantitative surveys. Phase one outcomes will be used to inform site selection for MBC implementation and to facilitate adaptation of an MBC assessment protocol. Phase two will involve a pilot type 1 hybrid effectiveness-implementation study with four OTPs. The PI will work with the OTPs to integrate MBC into electronic medical record documentation procedures. Treatment providers will also receive MBC training and ongoing support, and preliminary MBC effectiveness and implementation data will be collected.

Results of this rigorous, mixed methods study will set the stage for future research focused on scaling up MBC to enhance the quality of care in OTPs. To conduct this high impact study, the PI requires training in four key areas:

  1. Development and management of community-engaged partnerships to support effectiveness and implementation trials in addiction treatment
  2. Evidence-based assessment and intervention methods for OUD
  3. Mixed methods data collection using rapid ethnography
  4. Measure design and adaptation

These training aims are supported by the Center for Dissemination & Implementation Science as well as by the candidate’s mentorship team. The mentorship team is led by primary mentor Sara Becker, PhD, and supported by Francesca Beaudoin, MD, PhD, MS; Lawrence Palinkas, PhD; and Melissa Clark, PhD.

Project Details

  • Dates: April 2021 – February 2026
  • Funding source: National Institute on Drug Abuse
  • Grant number: K23DA050729

Contact